Recent research findings indicated that finasteride may possess anti-inflammatory properties that reduce multiple inflammatory factors, including NOS2, NOX4, and COX2, in murine models of BPH (Lee et al., 2023). Here, NOX4 is linked to benign prostatic hyperplasia.